Original Research
This article aims to describe estimated prevalence of integrase strand transfer inhibitor resistance within a single clinic network in Chicago, IL, USA, and identify risk factors for resistance and virological failure.
Review
This article evaluates existing literature through such means as drug databases and package inserts along with PubMed/Medline, Embase, and Google Scholar databases to develop a reference tool for providers to utilize when there is a decision to treat a patient with ART and oral oncolytic agents concurrently.
